These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3130455)

  • 1. Differential induction of H-2K versus H-2D class I major histocompatibility antigens by recombinant gamma interferon. Lack of Kk augmentation in a leukemia virus-induced tumor is due to a cis-dominant effect.
    Green WR; Rich RF; Beadling C
    J Exp Med; 1988 May; 167(5):1616-24. PubMed ID: 3130455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential up-regulation of H-2D versus H-2K class I major histocompatibility expression by interferon-gamma: evidence against a trans-acting allele-specific factor.
    Rich RF; Gaffney KJ; White HD; Green WR
    J Interferon Res; 1990 Oct; 10(5):505-14. PubMed ID: 2125631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.
    Green WR; Phillips JD
    J Immunol; 1986 Aug; 137(3):814-8. PubMed ID: 3088110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
    Milling SW; Silvers WK; Sai T; Mintz B
    Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of the H-2Dk gene into a class I-negative tumor cell line confers interferon-gamma inducibility upon the silent endogenous H-2Kk gene.
    Rosenthal LA; Klyczek KK; Blank KJ
    Cell Immunol; 1992 Nov; 145(1):43-55. PubMed ID: 1423645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines.
    Klyczek KK; Murasko DM; Blank KJ
    J Immunol; 1987 Oct; 139(8):2641-8. PubMed ID: 3116091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line.
    Maudsley DJ; Morris AG
    J Exp Med; 1988 Feb; 167(2):706-11. PubMed ID: 2831293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.
    Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B
    J Virol; 2000 Jun; 74(11):5363-7. PubMed ID: 10799615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant allele-specific regulation of expression of H-2Kk gene products revealed by somatic cell hybridization.
    Bishop CE; Lewis CM; Festenstein H
    Somatic Cell Genet; 1982 Sep; 8(5):623-34. PubMed ID: 7135165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
    Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
    Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis.
    Geldhof AB; VandenDriessche T; Opdenakker G; De Baetselier P
    Cancer Immunol Immunother; 1996 Jul; 42(6):329-38. PubMed ID: 8830735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo reexpression of H-2 antigens in B16 melanoma cells.
    Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
    Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated expression of tumor-specific and MHC class I antigens in an ultraviolet radiation-induced murine skin cancer.
    Ananthaswamy HN
    J Invest Dermatol; 1988 Mar; 90(3):263-6. PubMed ID: 2450140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.